Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)

被引：17

作者：

Abou-Alfa, Ghassan K.

Qin, Shukui

Ryoo, Baek-Yeol

Lu, Sheng-Nan

Yen, Chia-Jui

Feng, Yin-Hsun

Lim, Ho Yeong

Izzo, Francesco

Colombo, Massimo

Sarker, Debashis

Bolondi, Luigi

Vaccaro, Gina M.

Harris, William Proctor

Chen, Zhendong

Hubner, Richard

Meyer, Tim

Bomalaski, John S.

Lin, ChenChun

Chao, Yee

Chen, Li-Tzong

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Chinese Peoples Liberat Army 81 Hosp, Nanjing, Peoples R China

[3] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea

[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[5] Natl Cheng Kung Univ Hosp, Tainan, Taiwan

[6] Chi Mei Med Ctr Yongkang, Tainan, Taiwan

[7] Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea

[8] Naples G Pascale Fdn, Natl Canc Inst, Naples, Italy

[9] Maggiore Hosp, Milan, Italy

[10] Kings Coll Hosp London, Dept Oncol, London, England

[11] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy

[12] St Orsola Marcello Malpighi Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy

[13] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[14] Univ Washington, Sch Med, Seattle, WA USA

[15] Anhui Med Univ, Hosp 2, Hefei, Peoples R China

[16] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England

[17] UCL, UCL Canc Inst, London, England

[18] Polaris Pharmaceut Inc, San Diego, CA USA

[19] Chang Gung Med Foundatio LK, Taoyuan, Taiwan

[20] Taipei Vet Gen Hosp, Taipei, Taiwan

[21] Natl Inst Canc Res, Natl Hlth Res Inst, Taipei, Taiwan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.4017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4017

引用

页数：2